Explore our strategy and projects
to learn about the future of our company
Results FY 2022 (€/MLN)
1,361
Revenues
514
Adjusted EBITDA
319
Adjusted net profit
316
Free cash flow
2023 Investor Day: Diasorin 3.0
On December 15, 2023 Diasorin Management Team presented the new Business Plan.
Keep
in touch
Sign up for our investor alerts
and stay informed
on the latest developments